GlaxoSmithKline plc (GSK) Price Target Cut to GBX 1,760 by Analysts at Berenberg Bank
GlaxoSmithKline plc (LON:GSK) had its price target cut by Berenberg Bank from GBX 1,835 ($24.21) to GBX 1,760 ($23.23) in a research note issued to investors on Thursday morning. They currently have a buy rating on the stock.
Several other research firms have also recently commented on GSK. UBS AG set a GBX 1,600 ($21.11) price target on shares of GlaxoSmithKline plc and gave the company a neutral rating in a report on Wednesday, July 26th. HSBC Holdings plc set a GBX 1,925 ($25.40) price target on shares of GlaxoSmithKline plc and gave the company a buy rating in a report on Thursday, October 26th. Deutsche Bank AG set a GBX 1,610 ($21.25) price target on shares of GlaxoSmithKline plc and gave the company a neutral rating in a report on Friday, October 27th. Goldman Sachs Group, Inc. (The) set a GBX 1,900 ($25.07) price target on shares of GlaxoSmithKline plc and gave the company a buy rating in a report on Tuesday, August 8th. Finally, Jefferies Group LLC restated a buy rating and set a GBX 1,900 ($25.07) price target on shares of GlaxoSmithKline plc in a report on Thursday, July 13th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and six have assigned a buy rating to the stock. GlaxoSmithKline plc currently has an average rating of Hold and a consensus target price of GBX 1,619.75 ($21.37).
GlaxoSmithKline plc (LON GSK) traded up GBX 9.50 ($0.13) during trading on Thursday, hitting GBX 1,361 ($17.96). 7,047,222 shares of the stock traded hands.
GlaxoSmithKline plc (LON:GSK) last posted its quarterly earnings results on Wednesday, October 25th. The company reported GBX 32.50 ($0.43) EPS for the quarter, beating the consensus estimate of GBX 31.80 ($0.42) by GBX 0.70 ($0.01). GlaxoSmithKline plc had a negative net margin of 1.17% and a negative return on equity of 57.19%. The business had revenue of GBX 784.30 billion for the quarter.
The business also recently disclosed a dividend, which will be paid on Thursday, January 11th. Stockholders of record on Thursday, November 9th will be given a dividend of GBX 19 ($0.25) per share. This represents a dividend yield of 1.41%. The ex-dividend date is Thursday, November 9th.
In related news, insider Urs Rohner acquired 473 shares of the business’s stock in a transaction dated Wednesday, October 25th. The stock was acquired at an average price of GBX 1,518 ($20.03) per share, with a total value of £7,180.14 ($9,474.98). Also, insider Simon Dingemans acquired 1,076 shares of the business’s stock in a transaction dated Thursday, October 12th. The shares were bought at an average cost of GBX 1,527 ($20.15) per share, with a total value of £16,430.52 ($21,681.87). Insiders have bought 1,574 shares of company stock valued at $2,398,888 in the last ninety days.
About GlaxoSmithKline plc
GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with Analyst Ratings Network's FREE daily email newsletter.